1.
Association of Initial Twice-Weekly Hemodialysis Treatment with Preservation of Residual Kidney Function in ESRD Patients
by Zhang, Minmin
American journal of nephrology, 2014-09, Vol.40 (2), p.140-150

2.
Urinary Periostin Excretion Predicts Renal Outcome in IgA Nephropathy
by Hwang, Jin Ho
American journal of nephrology, 2016-12, Vol.44 (6), p.481-492

3.
Oxidative Balance Score and Chronic Kidney Disease
by Ilori, Titilayo O
American journal of nephrology, 2015-11, Vol.42 (4), p.320-327

4.
Oxalate Quantification in Hemodialysate to Assess Dialysis Adequacy for Primary Hyperoxaluria
by Tang, Xiaojing
American journal of nephrology, 2014-06, Vol.39 (5), p.376-382

5.
Glomerular and Tubular Epithelial Defects in kd/kd Mice Lead to Progressive Renal Failure
by Madaio, Michael P
American journal of nephrology, 2005-12, Vol.25 (6), p.604-610

6.
Effect of Erythropoietin on Urinary Liver-Type Fatty-Acid-Binding Protein in Patients with Chronic Renal Failure and Anemia
by Nakamura, Tsukasa
American journal of nephrology, 2006-07, Vol.26 (3), p.276-280

7.
Urinary Deoxypyridinoline Excretion for the Evaluation of Bone Turnover in Chronic Renal Failure
by Coen, Giorgio
American journal of nephrology, 2000-08, Vol.20 (4), p.283-290

8.
Urinary Epidermal Growth Factor Excretion in Children with Chronic Renal Failure
by Tsau, Yong-Kwei
American journal of nephrology, 1999-06, Vol.19 (3), p.400-404

9.
Mechanisms Contributing to Adverse Cardiovascular Events in Patients with Type 2 Diabetes Mellitus and Stage 4 Chronic Kidney Disease Treated with Bardoxolone Methyl
by Chin, Melanie P
American journal of nephrology, 2014-07, Vol.39 (6), p.499-508

10.
Effect of Bardoxolone Methyl on Kidney Function in Patients with T2D and Stage 3b–4 CKD
by Pergola, Pablo E
American journal of nephrology, 2011-05, Vol.33 (5), p.469-476

11.
Neutrophil Gelatinase-Associated Lipocalin in Patients with Autosomal-Dominant Polycystic Kidney Disease
by Bolignano, Davide
American journal of nephrology, 2007-07, Vol.27 (4), p.373-378

12.
Use of Extended-Release Calcifediol to Treat Secondary Hyperparathyroidism in Stages 3 and 4 Chronic Kidney Disease
by Sprague, Stuart M
American journal of nephrology, 2016-10, Vol.44 (4), p.316-325

13.
The Effect of Mild Hyperuricemia on Urinary Transforming Growth Factor Beta and the Progression of Chronic Kidney Disease
by Talaat, Khaled M
American journal of nephrology, 2007-09, Vol.27 (5), p.435-440

14.
Medication Intervention for Chronic Kidney Disease Patients Transitioning from Hospital to Home: Study Design and Baseline Characteristics
by Alicic, Radica Z
American journal of nephrology, 2016-09, Vol.44 (2), p.122-129

15.
Tubulointerstitial Fibrosis of Living Donor Kidneys Associates with Urinary Monocyte Chemoattractant Protein 1
by Wang, Xiangling
American journal of nephrology, 2016-07, Vol.43 (6), p.454-459

16.
Rationale, Design, and Baseline Characteristics of ARTS-DN: A Randomized Study to Assess the Safety and Efficacy of Finerenone in Patients with Type 2 Diabetes Mellitus and a Clini...
by Ruilope, Luis M
American journal of nephrology, 2015-02, Vol.40 (6), p.572-581

17.
The Effect of a Diet Containing 70% Protein from Plants on Mineral Metabolism and Musculoskeletal Health in Chronic Kidney Disease
by Moorthi, Ranjani N
American journal of nephrology, 2015-02, Vol.40 (6), p.582-591

18.
Furosemide Increases the Risk of Hyperparathyroidism in Chronic Kidney Disease
by Vasco, Raquel F.V
American journal of nephrology, 2016-07, Vol.43 (6), p.421-430

19.
Trefoil Factor 3 Predicts Incident Chronic Kidney Disease: A Case-Control Study Nested within the Atherosclerosis Risk in Communities (ARIC) Study
by Astor, Brad C
American journal of nephrology, 2011-10, Vol.34 (4), p.291-297

20.
Best Albuminuria Measurement to Predict Cardiovascular and Renal Events
by Bauer, Lucie
American journal of nephrology, 2016-06, Vol.43 (5), p.383-388
